Close Menu

NEW YORK (GenomeWeb) — Ag-bio startup Amfora announced today that it has acquired a nonexclusive license to intellectual property covering CRISPR-Cas9 genome editing and related technologies from DowDuPont's Corteva Agriscience and the Broad Institute.

San Francisco-based Amfora, which closed a $5 million Series A round roughly two years ago, aims to develop nutritionally enhanced food and feed crops. Under the terms of the license, Amfora will be able to use the IP to develop crops with increased protein content.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Nobel laureates and scientific societies urge NIH and the Department of Health and Human Services to revisit the recent decision to end funding for a coronavirus grant.

Bloomberg reports that BGI's SARS-CoV-2 testing sites in the Middle East have raised concerns among US officials.

A new Pew Research Center poll finds confidence in medical researchers has grown among US adults since the start of the coronavirus pandemic.

In Science this week: machine learning algorithm for faster Mendelian disorder diagnoses, gene linked to safe response to nitrogen-containing bisphosphonates, and more.